Abdurrahman Işıkdoğan

2.0k citations
146 papers · 1.2k indexed · h-index 19
  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies 21
    • Cancer Diagnosis and Treatment 12
    • HER2/EGFR in Cancer Research 12
    • Cancer Treatment and Pharmacology 11
    • Lung Cancer Treatments and Mutations 17
    • Gastric Cancer Management and Outcomes 12
    • Lung Cancer Diagnosis and Treatment 12
    • Breast Cancer Treatment Studies 16
  • Hepatology top 10%

Abdurrahman Işıkdoğan

133 papers receiving 1.2k citations

Peers

Abdurrahman Işıkdoğan
Comparison fields: 5 of 94
  • Oncology 537
  • Internal Medicine 60
  • Pulmonary and Respiratory Medicine 424
  • Cancer Research 186
  • Hepatology 69
Replace Faysal Dane with:
Faysal Dane Türkiye
Lina Tang China
Ugo Pace Italy
Thorsten Fuereder Austria
Kyoung Ha Kim South Korea
Antonio Piñero Spain
Christof Kaltenmeier United States
Herbert Stöger Austria
Donald C. Doll United States
Hou‐Qun Ying China
Abdurrahman Işıkdoğan relative to Faysal Dane Türkiye Faysal Dane's profile →
Citations per field
00.5×1.5×2.5×
Faysal Dane · 1×
Citations per year

Countries citing papers authored by Abdurrahman Işıkdoğan

Since Specialization
Citations

This map shows the geographic impact of Abdurrahman Işıkdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdurrahman Işıkdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdurrahman Işıkdoğan more than expected).

Fields of papers citing papers by Abdurrahman Işıkdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdurrahman Işıkdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdurrahman Işıkdoğan. The network helps show where Abdurrahman Işıkdoğan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Abdurrahman Işıkdoğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abdurrahman Işıkdoğan Line = papers co-authored together Abdurrahman Işıkdoğan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20242
4 20230
5 20221
6 20221
7
The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.
20201
8
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
20202
9 20192
10
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
20183
11
Mixed Ger m Cell Testis Tumor Presenting w ith Massive Lung Metastasis
20180
12 201415
13 20134
14
Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.
20132
15 20136
16 201216
17 20102
18
Türkiye’de meme kanseri erken tanı ve tarama programlarının hazırlanması “Sağlık Bakanlığı meme kanseri erken tanı ve tarama alt kurulu raporu”*
20093
19 20091
20
Breast carcinoma metastasis to the tail of pancreas
20091

About Abdurrahman Işıkdoğan

Abdurrahman Işıkdoğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 146 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Lung Cancer Treatments and Mutations (17 papers), Breast Cancer Treatment Studies (16 papers), Gastric Cancer Management and Outcomes (12 papers), Cancer Diagnosis and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (12 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Oncology (537 citations), Internal Medicine (60 citations) and Pulmonary and Respiratory Medicine (424 citations). Abdurrahman Işıkdoğan has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Kaplan Ma, Ali̇ İnal, Mehmet Küçüköner, Zuhat Urakçı, Timuçin Çil, Abdullah Altıntaş, Abdullah Büyükçelik, Orhan Ayyıldız, Berna Öksüzoğlu and Naci Tiftik. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026